|本期目录/Table of Contents|

[1]王晶,陈良安.克雷白菌属相关感染疾病及其耐药机制研究进展[J].慢性病学杂志,2014,(04):270-273.
点击复制

克雷白菌属相关感染疾病及其耐药机制研究进展(PDF)

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:
期数:
2014年04期
页码:
270-273
栏目:
综述
出版日期:
2014-06-27

文章信息/Info

Title:
-
作者:
王晶1; 2; 陈良安1
1.中国人民解放军总医院呼吸内科，北京100001；2.首都医科大学附属北京世纪坛医院呼吸内科，北京100038
Author(s):
-
关键词:
克雷伯菌属; 感染; 毒力; 耐药
Keywords:
-
分类号:
R378
DOI:
-
摘要:
克雷白杆菌属细菌(Klebsiella)多不直接致病，但在器官移植、应用激素、肿瘤，尤其是糖尿病患者， 易被此类细菌感染。在免疫力低下的患者中，进行有创操作、手术和侵袭性医源性操作的人群更易感染。 克雷白杆菌属细菌是社区获得性肺炎和医院获得性肺炎、护理机构相关性肺炎中的常见病原体之一。本文 对克雷白杆菌引起肺部炎症的毒力和耐药性主要是其在肺部感染中的地位和作用进行综述。
Abstract:
-

参考文献/References:

[1]Agley ST, Seidler RL, Brenner DJ. Klebsiella plantcola sp. nov: a new speciesof enterobacteriaceae found primarily in non? clinicalenvironments［J］．CurrMicrobiol,1981,6:105-109
[2］ Gavini FD, Izard PA, Grimont A. Priority of klebsiella planti? cola multicenterevaluation of the Micro Scan Rapid gram nega? tive identification type panel ［J］．Int J Syst Bacteriol,1983, 36:486-488.
[3］Sakazaki R, Tamura Y, Kosako Y. Klebsiella ornitbinolytica sp. Nov., formerly known as ornithine-positive klebsiella oxy? toca［J］．Curr Microliol,1989,18:201-206.
[4］Valles J, Leon C, Alvarez-Lerma F. Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemi? ology and prognosis. Spanish Collaborative Group for Infec? tions in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC)［J］．Clin Infect Dis,1997,24(3):387-395.
[5］Takayanagi N, Kagiyama N, Ishiguro T,et al. Etiology and outcome of community-acquired lung abscess［J］．Respira? tion,2010,80(2):98-105.
[6］李二红,李文军,文进.克雷白杆菌肺炎57例临床分析［J］．人 民军医,2006,49(10):601-602.
[7］姚泽忠,杭金国,汤卫红,等.230例婴幼儿肺炎克雷白杆菌肺炎 临床特点与抗菌治疗研究［J］．中国小儿急救医学,2011,18 (5):437-439.
[8］赵妍,高淑贤,魏春荣,等.克雷白杆菌肺炎27例临床分析［J］． 临床医学,2002,22(8):21-23.
[9］Blot SI, Vandewoude KH, Colardyn FA. Evaluation of out? come in critically ill patients with nosocomial enterobacter bac? teremia: results of a matched cohort study［J］．Chest,2003, 123(4):1208-1213.
[10］Daikos GL, Markogiannakis A, Souli M,et al. Bloodstream infections caused by carbapenemase- producing Klebsiella pneumoniae: a clinical perspective［J］．Expert Rev Anti Infect Ther,2012,10(12):1393-1404.
[11］Niu MT, Knippen M, Simmons L,et al. Transfusion-trans? mitted Klebsiella pneumoniae fatalities,1995to 2004 ［J］． Transfus Med Rev,2006,20(2):149-157.
[12］Blot S, Vandewoude K, De Bacquer D,et al. Nosocomial bac? teremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospital? ization ［J］．Clin InfectDis,2002,34(12):1600-1606.
[13］潘天力.肺炎克雷白氏杆菌败血症2例报告［J］．北京医科大学 学报,1991,28(4):68.
[14］Motta C, Salmeri M, Anfuso CD,et al. Klebsiella pneumoni? ae induces an inflammatory response in an in vitro model of blood- retinal barrier［J］．Infect Immun, 2014,82(2):851-863.
[15］Orskov IMA. New klebsiella capsular antigen, K82, and the deletion of five of those previously assigned［J］．Int J Syst Bacteriol,1977,27:386-387.
[16］Pan YJ, Fang HC, Yang HC,et al. Capsular polysaccharide synthesis regions in Klebsiella pneumoniae serotype K57and a new capsular serotype［J］．J Clin Microbiol, 2008,46(7): 2231-2240.
[17］Simoons- Smit AM, Verweij- van Vaught AM, MacLaren DM. The role of K antigen as virulence factors in Klebsiella ［J］．J Med Microbiol,1986,21(2):133-137.
[18］Yu WL, Ko WC, Cheng KC,et al. Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2and non-K1/K2sero? types ［J］．Diagn MicrobiolInfectDis,2008,62(1):1-6.
[19］Palfreyman JM. Klebsiella serotyping by counter-current im? munoelectrophoresis［J］．J Hyg (Lond),1978,81:219-225.
[20］Kawai T. Hypermucoviscosity: an extremely sticky phenotype of Klebsiella pneumoniae associated with emerging destructive tissue abscess syndrome［J］．Clin Infect Dis,2006,42(10): 1359-1361.
[21］Chuang YP, Fang CT, Lai SY,et al. Genetic determinants of capsular serotype K1of Klebsiella pneumoniae causing primary pyogenic liver abscess［J］．J Infect Dis, 2006,193(5):645-654.
[22］吴文乾.产超广谱β-内酰胺酶肺炎克雷白杆菌的体外耐药分析 ［J］．中国小儿急救医学,2014,14(4):300-301.
[23］施金玲,李从荣,蔡璇,等.产质粒介导AmpC酶肺炎克雷白杆菌 在下呼吸道感染中的流行研究［J］．医药导报,2009,18(1): 17-20.
[24］谭肖鹏,何丽容,陈巧伦,等.239株革兰阴性杆菌超广谱β-内酰 胺酶的检测及耐药性分析［J］．新医学,2003,34(4):214-216.
[25］Lemmenmeier E, Kohler P, Bruderer T,etal.Firstdocument? ed outbreak of KPC-2- producing Klebsiella pneumoniae in Switzerland: infection control measures and clinical manage? ment［J］．Infection,2014.DOI,10.1007/s15010-013-0578-9.［Epub ahead ofprint］
[26］张再跃.产β-内酰胺酶大肠埃希杆菌、肺炎克雷白杆菌耐药性 与抗菌药物消耗量相关性研究［J］．泰山医学院学报,2008,29 (3):179-182.
[27］Ramos PI, Picao RC, Almeida LG,et al. Comparative analy? sis of the complete genome of KPC-2- producing Klebsiella pneumoniae Kp13reveals remarkable genome plasticity and a wide repertoire of virulence and resistance mechanisms［J］． BMC Genomics,2014,15(1):54.

备注/Memo

备注/Memo:
作者简介：王晶，硕士，副主任医师，主要从事呼吸危 重症、感染、COPD等研究 通信作者：陈良安，E-mail: jyc6636@126.com
更新日期/Last Update: 2014-04-30